Wish to keep on high of the science and politics driving biotech as we speak? Enroll to get our biotech publication in your inbox.
Immediately we speak in regards to the midsummer chill within the biotech market right here in my dwelling city of San Diego. Additionally, we be taught that it was FDA most cancers chief Richard Pazdur’s intervention that contributed to the rejection of Replimune’s melanoma drug — not Vinay Prasad.
Biotech winter freezes jobs, however not hope in SoCal
San Diego’s once-sizzling biotech scene is now in a chilly snap. It’s left some staff determined after months of fruitless job trying to find vanishing alternatives, STAT’s Jonathan Wosen writes, whereas emptiness charges for lab house have surged from 1% to over 22% as corporations slash prices.
This text is unique to STAT+ subscribers
Unlock this text — plus in-depth evaluation, newsletters, premium occasions, and information alerts.
Have already got an account? Log in
To learn the remainder of this story subscribe to STAT+.
